首页> 美国卫生研究院文献>BMC Genomics >Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns
【2h】

Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns

机译:次小内含子剪接:重新鉴定新的含小内含子的基因和组织依赖性保留和替代剪接的内含子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMutations in minor spliceosome components such as U12 snRNA (cerebellar ataxia) and U4atac snRNA (microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1)) result in tissue-specific symptoms. Given that the minor spliceosome is ubiquitously expressed, we hypothesized that these restricted phenotypes might be caused by the tissue-specific regulation of the minor spliceosome targets, i.e. minor intron-containing genes (MIGs). The current model of inefficient splicing is thought to apply to the regulation of the ~ 500 MIGs identified in the U12DB. However this database was created more than 10 years ago. Therefore, we first wanted to revisit the classification of minor introns in light of the most recent reference genome. We then sought to address specificity of MIG expression, minor intron retention, and alternative splicing (AS) across mouse and human tissues.
机译:背景较小的剪接体成分(例如U12 snRNA(小脑性共济失调)和U4atac snRNA(微头状骨发育异常的原始侏儒症1型(MOPD1))突变会导致组织特异性症状。鉴于次要剪接体无处不在表达,我们假设这些限制性表型可能是由次要剪接体靶标的组织特异性调节(即次要含内含子的基因(MIG))引起的。当前的低效拼接模型被认为适用于U12DB中确定的约500个MIG。但是,此数据库是在10多年前创建的。因此,我们首先要根据最新的参考基因组重新探讨次要内含子的分类。然后,我们试图解决MIG表达的特异性,较小的内含子保留以及跨小鼠和人类组织的选择性剪接(AS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号